2BB score and signals
Zenas BioPharma, Inc.’s current 2BB score is 58 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 79 | High |
| Momentum | 71 | Improving |
| Financial strength | 19 | Very Weak |
| Quality | 98 | Very Strong |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2019 |
| Employees | 167 |
| 52-week range | $13.50 – $44.54 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-15 | — | -1.2968 | — | $0.00 |
| 2026-11-10 | — | -1.2684 | — | $0.00 |
| 2026-08-18 | — | -1.147 | — | $19.12M |
| 2026-05-13 | -1.46 | -1.6177 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish